MedTrace Logo

Use of Simucase for Clinical Learning in Malaysia

NCT06777550 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-01-17

No results posted yet for this study

Summary

The goal of this feasibility study is to the investigate the use of Simucase in the context of health science learning in Malaysia. This study can be a catalyst for technology-based clinical learning than just conventional methods to enrich the learning experience. This can influence the policy in promoting the effective use of existing commercial technologies in clinical learning for health science programs in Malaysia and can transform national higher education scenario in the future.

An experimental study with 24 participants from the rehabilitation disciplines of audiology, occupational therapy, physiotherapy, and speech therapy method using a pilot study techniques of clinical control studies. Participants will be assigned to either the experimental group who will receive the clinical learning method using SimucaseTM or (ii) the control group - which will accept conventional clinical learning methods such as problem-based learning case-study case studies. The topic of learning is the same for both groups.

The study hypothesis includes:

* There is a significant difference on clinical skills between SimucaseTM and conventional approach of learning among health science students.
* There is a significant difference on students' satisfaction learning between SimucaseTM and conventional approach of learning among health science students.

Conditions

  • Clinical Learning

Interventions

OTHER

SimucaseTM

experiment group - who will receive the clinical learning method using SimucaseTM

OTHER

Conventional Clinical Learning

Problem-based learning case-study case studies

Sponsors & Collaborators

  • Universiti Putra Malaysia

    collaborator OTHER

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Farahiyah Wan Yunus, Doctor of Philosophy · National University of Malaysia

  • Muhammad H Romli, Doctor of Philosophy · Universiti Putra Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-19
Primary Completion
2025-12-25
Completion
2025-12-25

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06777550 on ClinicalTrials.gov